The latest closing stock price for Aptevo Therapeutics as of May 09, 2025 is 0.34.
An investor who bought $1,000 worth of Aptevo Therapeutics stock at the IPO in 2016 would have $-1,000 today, roughly -1 times their original investment - a -76.91% compound annual growth rate over 9 years.
The all-time high Aptevo Therapeutics stock closing price was 182336.00 on July 20, 2016.
The Aptevo Therapeutics 52-week high stock price is 33.70, which is 9811.8% above the current share price.
The Aptevo Therapeutics 52-week low stock price is 0.34, which is 0% below the current share price.
The average Aptevo Therapeutics stock price for the last 52 weeks is 9.77.
An investor who bought $1,000 worth of Aptevo Therapeutics stock at the IPO in 2016 would have $-1,000 today, roughly -1 times their original investment - a -76.91% compound annual growth rate over 9 years.
The all-time high Aptevo Therapeutics stock closing price was 182336.00 on July 20, 2016.
The Aptevo Therapeutics 52-week high stock price is 33.70, which is 9811.8% above the current share price.
The Aptevo Therapeutics 52-week low stock price is 0.34, which is 0% below the current share price.
The average Aptevo Therapeutics stock price for the last 52 weeks is 9.77.